9,430
Views
21
CrossRef citations to date
0
Altmetric
Review

The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy

ORCID Icon, &
Article: 2167189 | Received 21 Jul 2022, Accepted 06 Jan 2023, Published online: 01 Feb 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.